Skip to content
Aperlena
Language:

Germany - Medicines - Discount agreements for medicines from 01.02.2026 for various active ingredients under an Open House procedure

Original Deutschland - Arzneimittel - Arzneimittel-Rabattverträge ab 01.02.2026 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens

Open Contract notice 430 days left
Watch this tender

Deadline 1 Dec. If it moves, an email when the register sees it. A correction: the same email. Your plan: decide by 17 Nov, questions by 17 Nov, draft by 24 Nov. Log in

  1. Published
  2. Today
  3. Deadline open for 567 days
  4. Awarded pending

Summary

Machine-generated summary

A German statutory health insurance buyer is concluding rebate contracts for medicines under Section 130a paragraph 8 of the German Social Code Book V for various active ingredients. The procedure is an Open House model: uniform contract terms and a uniform access procedure are offered to all suitable and interested pharmaceutical companies or consortia of pharmaceutical companies. Contracts can be joined throughout the process. The earliest contract start date is 01.02.2026, with a maximum contract duration of 24 months from that date.

Description

Gegenstand dieser Veröffentlichung ist der Abschluss von Verträgen nach § 130a Abs. 8 SGB V für diverse Wirkstoffe im Rahmen eines sogenannten Open-House-Verfahrens: Unter Vorgabe einheitlicher Vertragskonditionen sowie eines einheitlichen Zugangsverfahrens wird allen geeigneten und interessierten pharmazeutischen Unternehmen oder Gemeinschaften pharmazeutischer Unternehmen der Abschluss von Rabattverträgen nach § 130a Abs. 8 SGB V angeboten. Der früheste Vertragsbeginn ist der 01.02.2026. Davon ausgehend beträgt die Vertragslaufzeit maximal 24 Monate. Unter Vorgabe einheitlicher Vertragskonditionen sowie eines einheitlichen Zugangsverfahrens wird allen geeigneten und interessierten pharmazeutischen Unternehmen oder Gemeinschaften pharmazeutischer Unternehmen der Abschluss von Rabattverträgen nach § 130a Abs. 8 SGB V über die genannten Wirkstoffe angeboten. Der früheste Vertragsbeginn ist der 01.02.2026. Davon ausgehend beträgt die Vertragslaufzeit maximal 24 Monate.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 month ago

View the official notice

More from this buyer

Full buyer profile

10 open tenders right now

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Germany

Company Wins Total awarded Last win
Siemens Healthineers AG 42 €17.4M Sep 2026
Philips GmbH 20 €5.3M Sep 2026
GlaxoSmithKline GmbH & Co. KG 15 n/a Sep 2026
ASTRAZENECA GMBH 12 n/a Jul 2026
Brainlab Sales GmbH 10 €4.0M Sep 2026

Based on 1018 awards with a linked company profile over the last 2 years.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Act now
    • Submission deadline: Moved 1 day EARLIER: now December 1, 2027, 00:00
    • Scope and criteria: The description was expanded. Re-read it before you bid.

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,066,160
9,838 open across Europe right now
Buyer track record on Aperlena
14 notices tracked · 1 awarded

Never miss a tender like this

76 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

430 days left

Source

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close